Provided by Tiger Trade Technology Pte. Ltd.

LUCID DIAGNOSTICS INC.

1.36
-0.0200-1.45%
Volume:482.92K
Turnover:664.42K
Market Cap:186.63M
PE:-1.73
High:1.40
Open:1.37
Low:1.36
Close:1.38
52wk High:1.80
52wk Low:0.9495
Shares:137.23M
Float Shares:96.17M
Volume Ratio:0.60
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7866
EPS(LYR):-1.0497
ROE:-331.24%
ROA:-79.17%
PB:-6.56
PE(LYR):-1.30

Loading ...

Lucid Diagnostics Price Target Maintained With a $2.50/Share by BTIG

Dow Jones
·
Sep 11, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy

Reuters
·
Sep 11, 2025

Lucid Diagnostics Shares Fall After Pricing of Public Stock Offering

Dow Jones
·
Sep 10, 2025

BUZZ-Lucid Diagnostics slides on $25 mln stock sale

Reuters
·
Sep 10, 2025

Lucid Diagnostics Announces Pricing of Public Offering of Common Stock

THOMSON REUTERS
·
Sep 10, 2025

Lucid Diagnostics Plans Stock Offering

MT Newswires Live
·
Sep 10, 2025

BRIEF-Lucid Diagnostics Announces Proposed Public Offering Of Common Stock

Reuters
·
Sep 10, 2025

Lucid Diagnostics Is Maintained at Buy by BTIG

Dow Jones
·
Sep 05, 2025

BRIEF-Pavmed Signs Letter Of Intent To License Groundbreaking Endoscopic Esophageal Imaging Technology

Reuters
·
Aug 26, 2025

PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology

THOMSON REUTERS
·
Aug 26, 2025

PAVmed Inc - Executes Non-Binding Letter With Duke University for Technology

THOMSON REUTERS
·
Aug 26, 2025

PAVmed Inc - Lucid Diagnostics to Partner With PAVmed on Technology

THOMSON REUTERS
·
Aug 26, 2025

Dennis Matheis, Director, Reports Acquisition of Common Shares in Lucid Diagnostics Inc

Reuters
·
Aug 23, 2025

PAVmed Inc. Reports Q2 2025 Results: Revenue at $1.2 Million, GAAP Net Loss of $13.3 Million, EPS at $(0.74); Adjusted Loss at $1.8 Million, EPS at $(0.11)

Reuters
·
Aug 14, 2025

Lucid Diagnostics Price Target Maintained With a $3.00/Share by Needham

Dow Jones
·
Aug 14, 2025

Lucid Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 13, 2025

BRIEF-Lucid Diagnostics Inc QTRLY Loss Per Share $0.08

Reuters
·
Aug 13, 2025

Lucid Diagnostics Inc: Qtrly Shr Loss $0.08

THOMSON REUTERS
·
Aug 13, 2025

Lucid Diagnostics Q2 2025 Adj. EPS $(0.10) Beats $(0.12) Estimate, Sales $1.163M Miss $1.770M Estimate

Benzinga
·
Aug 13, 2025

Lucid Diagnostics Inc. Reports Q2 2025 Revenue of $1.2 Million, Processing 2,756 EsoGuard Tests

Reuters
·
Aug 13, 2025